AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Research Across America Announces Methamphetamine Addiction Treatment Protocol Study Results; More Than 80% of Study Participants Experienced Significant Clinical Benefit.
DALLAS -- Research Across America, a nationally-recognized clinical research center, today announced initial results of their study of the PROMETA(TM) treatment protocol for methamphetamine dependence. Board Certified Psychiatrist and addiction expert Harold C. Urschel, III, M.D., M.M.A. was lead investigator on this first clinical study of the PROMETA treatment for stimulant dependence.
Initial results from this study showed no adverse events and that more than 80% of study participants experienced a significant clinical benefit. For purposes of determining clinical benefit, patient improvement was measured by treatment completion, study retention, reduction in cravings and decrease in usage of or abstinence from methamphetamine. Dr. Urschel will present full study results at the College on Problems of Drug Dependence's annual meeting in Scottsdale, AZ on June 21, 2006.
The study was conducted on an outpatient basis, with subjects remaining in an environment where they were subject to triggers that…
- Hythiam Secures Patents Underlying PROMETA Treatment Protocols in China and...
- Press release article from: Business Wire June 7, 2007 700+ words
...combinations of these drugs. The PROMETA treatment protocols comprise nutritional...built around its proprietary PROMETA treatment protocols for alcoholism and dependence to stimulants. The PROMETA treatment protocols, which integrate...
- Bridge Back to Life to Offer Hythiam's PROMETA Treatment Protocol in Three...
- Press release article from: Business Wire May 11, 2006 700+ words
...suffer from this disease." About PROMETA Hythiam's PROMETA treatment protocols are designed for use by healthcare providers...methamphetamines, as well as combinations of these drugs. The PROMETA treatment protocols comprise FDA-approved oral and IV medications...
- Research provides further evidence for the mechanism of action underlying...
- News wire article from: Chemical Business Newsbase November 18, 2008 700+ words
...supporting a mechanism of action underlying the company's Prometa Treatment Programme. Dr Sheryl Smith, a leading researcher in the...withdrawal. The current study shows that a component of the Prometa Treatment Programme (Prometa) reverses the increase in both alpha...
- Pilot Program Involving Prometa Treatment Program and Standard of Care...
- Press release article from: Business Wire March 14, 2008 700+ words
...Bridges announced today the completion of a pilot program to assess the medical component of Hythiam's (NASDAQ:HYTM) Prometa Treatment Program (PTP) as a comparison to their standard ASAM medical detoxification protocol for Medicaid-eligible adults seeking...
- County gives $400,000 for Prometa treatment.(Pierce County Alliance)(Brief...
- Newspaper article from: Alcoholism & Drug Abuse Weekly April 23, 2007 700+ words
...people in family and drug court," said Teree Schmidt-Whelan, Ph.D., director of the Pierce County Alliance. The Prometa treatment protocol typically costs $12,000-$15,000 a person, according to Hythiam, the company that developed and licenses...
- Double-Blind, Placebo-Controlled Alcohol Study of Hythiam's Prometa Treatment...
- Press release article from: Business Wire July 8, 2008 700+ words
...1 * The data also provide clinical guidance as to the most appropriate therapeutic window during withdrawal to use the PROMETA Treatment Program on alcohol dependent patients. These data are initial results and additional data reviews of the full 14-week...
- U.S. Patent Office Allows Hythiam Patent Application Underlying the PROMETA...
- Press release article from: Business Wire January 10, 2008 700+ words
...to drink alcohol. The patent will serve to enhance protection of the intellectual property underlying the company's PROMETA Treatment Program. This patent, the second allowance in the U.S., represents the securing of the last of the initial patents...
- Investigators Observe Significant Reduction in Methamphetamine Cravings and Use...
- Press release article from: Business Wire October 1, 2007 700+ words
LOS ANGELES -- Hythiam, Inc. (NASDAQ:HYTM) today announced that the Mayo Clinic Proceedings medical journal published in their October installment, an open-label study by Dr. Harold C. Urschel, III, M.D., M.M.A. of the pharmacological component of the PROMETA([R]) Treatment Program for
- Study of PROMETA Protocol Shows Clinical Effectiveness; Statistically...
- Press release article from: Business Wire June 21, 2006 700+ words
...clinical study of the PROMETA treatment protocol for stimulant...experienced a significant clinical benefit with no adverse events. Clinical benefit was measured through...we were testing the PROMETA Treatment Protocols in an outpatient...
- Hythiam - Chmn. & CEO Interview.
- News wire article from: The America's Intelligence Wire May 16, 2006 700+ words
...The company releasing a study this morning that shows its Prometa treatment, a medicinal treatment that targets chemical receptors...percent of the patients in the study experienced significant clinical benefit which is just dramatic. It is the first treatment that...
Source: HighBeam Research, Research Across America Announces Methamphetamine Addiction Treatment...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
